denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Symposia: ASH-a-Palooza
Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Research, clinical trials, epidemiology, Clinical Practice (Health Services and Quality), Clinical Research
Hematology Disease Topics & Pathways:
Research, clinical trials, epidemiology, Clinical Practice (Health Services and Quality), Clinical Research
Friday, December 8, 2023: 1:30 PM-2:00 PM
Sections 122 and 124 C
(Petco Park)
Friday, December 8, 2023: 2:40 PM-3:10 PM
Sections 122 and 124 C
(Petco Park)
Speakers:
Morey Blinder, Washington University
,
Marc Carrier, MD, University of Ottawa
,
Julie Kanter, MD, University of Alabama At Birmingham
,
Alice Ma, MD, University of North Carolina at Chapel Hill
and
Sana Saif Ur Rehman, MD, Washington University
Disclosures:
Carrier: BMS-Pfizer: Honoraria, Research Funding; Leo Pharma: Honoraria, Research Funding; Bayer: Honoraria; Servier: Honoraria, Other: Payments made to my institution; Sanofi: Honoraria, Other: Payments made to my institution; Anthos: Honoraria, Other: Payments made to my institution. Kanter: Chiesi: Honoraria, Membership on an entity's Board of Directors or advisory committees; Austin Therapeutics: Honoraria, Membership on an entity's Board of Directors or advisory committees; Bausch: Honoraria; Watkins, Lourie, Roll&Chance: Consultancy; Guidepoint Global: Consultancy; Fulcrum: Consultancy; ECOR1: Consultancy; Beam: Consultancy, Honoraria; OptumRx: Consultancy; Novartis: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Bluebird Bio: Consultancy; GLG: Consultancy; Cowen: Consultancy. Ma: Pfizer: Membership on an entity's Board of Directors or advisory committees.